Acrivon Therapeutics, Inc. (ACRV)
(Delayed Data from NSDQ)
$9.36 USD
+0.67 (7.71%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $9.25 -0.11 (-1.18%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.56 | 0.00% |
Earnings Summary
For their last quarter, Acrivon Therapeutics, Inc. (ACRV) reported earnings of -$0.52 per share, beating the Zacks Consensus Estimate of $-0.59 per share. This reflects a positive earnings surprise of 11.86%. Look out for ACRV's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.56 per share, reflecting a year-over-year increase of 15.15%.
Earnings History
Price & Consensus
Zacks News for ACRV
Verastem (VSTM) Begins Dosing in Solid Tumors Study in China
ACRV: What are Zacks experts saying now?
Zacks Private Portfolio Services